Wachstumshormonmangel im Erwachsenenalter

Annette Bergner
Growth hormones (GH) do not just affect people‟s growth but they also have an impact on metabolic processes, immune system, fitness as well as quality of life. Since 1995, genetically engineered synthetic GH has been licensed in Germany for the treatment of adults with growth hormone deficiency (GHD). The licensing study for Genotropin (1992-1994) raised the hopes that the physical balance of patients with GHDA could be completely restored through GH treatment due to the...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.